137 related articles for article (PubMed ID: 33274240)
1. FOXP3 in Melanoma with Regression: Between Tumoral Expression and Regulatory T Cell Upregulation.
Cioplea M; Nichita L; Georgescu D; Sticlaru L; Cioroianu A; Nedelcu R; Turcu G; Rauta A; Mogodici C; Zurac S; Popp C
J Immunol Res; 2020; 2020():5416843. PubMed ID: 33274240
[TBL] [Abstract][Full Text] [Related]
2. Foxp3 expression in melanoma cells as a possible mechanism of resistance to immune destruction.
Niu J; Jiang C; Li C; Liu L; Li K; Jian Z; Gao T
Cancer Immunol Immunother; 2011 Aug; 60(8):1109-18. PubMed ID: 21547596
[TBL] [Abstract][Full Text] [Related]
3. The role of FoxP3+ regulatory T cells and IDO+ immune and tumor cells in malignant melanoma - an immunohistochemical study.
Salmi S; Lin A; Hirschovits-Gerz B; Valkonen M; Aaltonen N; Sironen R; Siiskonen H; Pasonen-Seppänen S
BMC Cancer; 2021 May; 21(1):641. PubMed ID: 34051744
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of tumoral PDL1 expression and peritumoral FoxP3+ lymphocytes in vulvar melanomas.
Chłopik A; Selim MA; Peng Y; Wu CL; Tell-Marti G; Paral KM; Shalin SC; Kraft S; Hsu CK; Shea CR; Puig S; Fernandez-Figueras MT; Biernat W; Ryś J; Marszalek A; Hoang MP
Hum Pathol; 2018 Mar; 73():176-183. PubMed ID: 29307625
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of intra-tumoral CD8
Sideras K; Galjart B; Vasaturo A; Pedroza-Gonzalez A; Biermann K; Mancham S; Nigg AL; Hansen BE; Stoop HA; Zhou G; Verhoef C; Sleijfer S; Sprengers D; Kwekkeboom J; Bruno MJ
J Surg Oncol; 2018 Jul; 118(1):68-76. PubMed ID: 29878369
[TBL] [Abstract][Full Text] [Related]
6. Phase- and stage-related proportions of T cells bearing the transcription factor FOXP3 infiltrate primary melanoma.
De Panfilis G; Campanini N; Santini M; Mori G; Tognetti E; Maestri R; Lombardi M; Froio E; Ferrari D; Ricci R
J Invest Dermatol; 2008 Mar; 128(3):676-84. PubMed ID: 17851585
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of tumor-infiltrating Foxp3+ T-cell subpopulations in metastatic melanoma.
Knol AC; Nguyen JM; Quéreux G; Brocard A; Khammari A; Dréno B
Exp Dermatol; 2011 May; 20(5):430-4. PubMed ID: 21410773
[TBL] [Abstract][Full Text] [Related]
8. Hypomethylation of the Treg-Specific Demethylated Region in FOXP3 Is a Hallmark of the Regulatory T-cell Subtype in Adult T-cell Leukemia.
Shimazu Y; Shimazu Y; Hishizawa M; Hamaguchi M; Nagai Y; Sugino N; Fujii S; Kawahara M; Kadowaki N; Nishikawa H; Sakaguchi S; Takaori-Kondo A
Cancer Immunol Res; 2016 Feb; 4(2):136-45. PubMed ID: 26681759
[TBL] [Abstract][Full Text] [Related]
9. Utility of tumour-infiltrating CD25+FOXP3+ regulatory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma.
Miracco C; Mourmouras V; Biagioli M; Rubegni P; Mannucci S; Monciatti I; Cosci E; Tosi P; Luzi P
Oncol Rep; 2007 Nov; 18(5):1115-22. PubMed ID: 17914561
[TBL] [Abstract][Full Text] [Related]
10. The regulation of immune tolerance by FOXP3.
Lu L; Barbi J; Pan F
Nat Rev Immunol; 2017 Nov; 17(11):703-717. PubMed ID: 28757603
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers.
Usó M; Jantus-Lewintre E; Bremnes RM; Calabuig S; Blasco A; Pastor E; Borreda I; Molina-Pinelo S; Paz-Ares L; Guijarro R; Martorell M; Forteza J; Camps C; Sirera R
Oncotarget; 2016 Aug; 7(33):52849-52861. PubMed ID: 27463005
[TBL] [Abstract][Full Text] [Related]
12. FOXP3+ cell density in primary tumor has no prognostic impact in patients with cutaneous malignant melanoma.
Ladányi A; Mohos A; Somlai B; Liszkay G; Gilde K; Fejos Z; Gaudi I; Tímár J
Pathol Oncol Res; 2010 Sep; 16(3):303-9. PubMed ID: 20306313
[TBL] [Abstract][Full Text] [Related]
13. Emerging Role of IL-4-Induced Gene 1 as a Prognostic Biomarker Affecting the Local T-Cell Response in Human Cutaneous Melanoma.
Ramspott JP; Bekkat F; Bod L; Favier M; Terris B; Salomon A; Djerroudi L; Zaenker KS; Richard Y; Molinier-Frenkel V; Castellano F; Avril MF; Prévost-Blondel A
J Invest Dermatol; 2018 Dec; 138(12):2625-2634. PubMed ID: 30048651
[TBL] [Abstract][Full Text] [Related]
14. Foxp3(high) and Foxp3(low) Treg cells differentially correlate with T helper 1 and natural killer cells in peripheral blood.
Lee SK; Kim JY; Jang BW; Hur SE; Na BJ; Lee M; Fukui A; Gilman-Sachs A; Kwak-Kim J
Hum Immunol; 2011 Aug; 72(8):621-6. PubMed ID: 21600259
[TBL] [Abstract][Full Text] [Related]
15. Demethylation of the FOXP3 gene in human melanoma cells precludes the use of this epigenetic mark for quantification of Tregs in unseparated melanoma samples.
Lucas S; van Baren N; de Smet C; Coulie PG
Int J Cancer; 2012 Apr; 130(8):1960-6. PubMed ID: 21618521
[TBL] [Abstract][Full Text] [Related]
16. Regulatory T Cells: the Many Faces of Foxp3.
Georgiev P; Charbonnier LM; Chatila TA
J Clin Immunol; 2019 Oct; 39(7):623-640. PubMed ID: 31478130
[TBL] [Abstract][Full Text] [Related]
17. The microenvironment in primary cutaneous melanoma with associated spontaneous tumor regression: evaluation for T-regulatory cells and the presence of an immunosuppressive microenvironment.
Gray A; Grushchak S; Mudaliar K; Kliethermes S; Carey K; Hutchens KA
Melanoma Res; 2017 Apr; 27(2):104-109. PubMed ID: 28125447
[TBL] [Abstract][Full Text] [Related]
18. High expression of FOXP3 in primary melanoma is associated with tumour progression.
Gerber AL; Münst A; Schlapbach C; Shafighi M; Kiermeir D; Hüsler R; Hunger RE
Br J Dermatol; 2014 Jan; 170(1):103-9. PubMed ID: 24116716
[TBL] [Abstract][Full Text] [Related]
19. [Impact of СD8/FoxP3 T lymphocyte ratio in the peritumoral area of primary cutaneous melanoma on the prognosis of the disease].
Bozhchenko YA; Vishnevskaya YV; Pokataev IA; Kokosadze NV; Demidov LV
Arkh Patol; 2016; 78(4):27-31. PubMed ID: 27600779
[TBL] [Abstract][Full Text] [Related]
20. Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers.
Saito T; Nishikawa H; Wada H; Nagano Y; Sugiyama D; Atarashi K; Maeda Y; Hamaguchi M; Ohkura N; Sato E; Nagase H; Nishimura J; Yamamoto H; Takiguchi S; Tanoue T; Suda W; Morita H; Hattori M; Honda K; Mori M; Doki Y; Sakaguchi S
Nat Med; 2016 Jun; 22(6):679-84. PubMed ID: 27111280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
